ghk-cu subcutaneous ghk cu or intramuscular Peptide GHK-Cu Peptide Therapy: The Definitive

Roxas and Viswanathan 2018)

If one were to extrapolate from existing human trials: Dose: 0.51 mg per day Route: Sublingual or subcutaneous Duration: Up to 20 days (as used in circadian gene studies) Yet these regimens should not be considered prescriptive or approved protocols

Supplements that use chemical names such as ascorbic acid (vitamin C) or only include individual nutrients are likely synthetic

have no restrictions and require no certifications or licenses from medical assistants for them to give injections or shots

BPC-157 helps with chronic tendinopathy based on its mechanism of action, targeting the degenerative tissue environment that defines the condition, though direct human clinical evidence for tendinopathy specifically does not exist